Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna-Reference-Cited by-同舟云学术

Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna

Published:2023-01 Issue: Volume:30 Page:100634
ISSN:2666-6065
Container-title:The Lancet Regional Health - Western Pacific
language:en
Short-container-title:The Lancet Regional Health - Western Pacific

Author:

Brault Antoine,Tran-Kiem Cécile,Couteaux Clément,Olié Valérie,Paireau Juliette,Yazdanpanah Yazdan,Ghosn Jade,Martin-Blondel Guillaume,Bosetti Paolo^ORCID,Cauchemez Simon^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Psychiatry and Mental health,Geriatrics and Gerontology,Public Health, Environmental and Occupational Health,Obstetrics and Gynecology,Health Policy,Pediatrics, Perinatology and Child Health,Internal Medicine

Reference35 articles.

1. Multi-faceted analysis of COVID-19 epidemic in Korea considering omicron variant: mathematical modeling-based study;Ko;J Korean Med Sci,2022

2. Modeling transmission of SARS-CoV-2 Omicron in China;Cai;Nat Med,2022

3. China can prepare to end its zero-COVID policy;Chen;Nat Med,2022

4. SARS-CoV-2 Omicron disease burden in Australia following border reopening: a modelling analysis;Milne;bioRxiv,2022

5. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19;Hammond;N Engl J Med,2022

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Utility Model of Nirmatrelvir/Ritonavir in Brazil: Analysis of a Vaccinated Population;Value in Health Regional Issues;2024-03

2. Antivirals for the treatment of mild and moderate COVID-19 in South Africa;South African Medical Journal;2023-12-04

3. Estimating the potential impact and diagnostic requirements for SARS-CoV-2 test-and-treat programs;Nature Communications;2023-12-02

4. Effects of novel Coronavirus (COVID-19) on presentation, management, and outcomes of acute cholecystitis at an academic tertiary care center cholecystitis management during COVID-19;Heliyon;2023-11

5. Risk estimation of lifted mask mandates and emerging variants using mathematical model;Heliyon;2023-06